Predictors of HIV-specific lymphocyte proliferative immune responses induced by therapeutic vaccination
Author:
Affiliation:
1. The Immune Response Corporation, Carlsbad, CA
2. U.S. Naval Hospital, Division of Infectious Diseases, San Diego, CA
3. Department of Medicine, SUNY at Stony Brook, NY, USA
Abstract
Publisher
Oxford University Press (OUP)
Subject
Immunology,Immunology and Allergy
Link
https://academic.oup.com/cei/article-pdf/128/2/359/42139899/j.1365-2249.2002.01835.x.pdf
Reference17 articles.
1. Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection;Eron;Lancet,1996
2. Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial;Goebel;AIDS,1999
3. Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults;Pontesilli;AIDS,1998
4. Sequence note: HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant;Choi;AIDS Res Hum Retroviruses,1997
5. Human immunodeficiency virus isolated from a serum sample collected in 1976 in Central Africa;Getchell;J Infect Dis,1997
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy;Vaccine;2008-05
2. Current Prospects for the Development of a Therapeutic Vaccine for the Treatment of HIV Type 1 Infection;AIDS Research and Human Retroviruses;2004-08
3. Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjects;Vaccine;2004-08
4. Immune Reconstitution and Viral Stimulation Are Required to Restore HIV-Specific CD8 T Cell Responses Following Advanced Infection;Journal of Clinical Immunology;2004-03
5. Role of therapeutic vaccines in the control of HIV-1;Journal of Antimicrobial Chemotherapy;2004-02-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3